Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126407982 | 12640798 | 2 | F | 20160716 | 20160803 | 20160810 | 20160816 | EXP | GB-MHRA-MIDB-02620444-98CF-4F3F-8F51-8DBB6F507814 | GB-PFIZER INC-2016373951 | PFIZER | 71.00 | YR | M | Y | 101.00000 | KG | 20160816 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126407982 | 12640798 | 1 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 220 MG, UNK | N | 0 | 220 | MG | |||||||
| 126407982 | 12640798 | 2 | PS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 1.5 G, 2X/DAY | 108 | G | 62911 | 1.5 | G | BID | |||||
| 126407982 | 12640798 | 3 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | IN MORNING. 80MG/400MG. | 0 | 480 | MG | TABLET | QD | |||||||
| 126407982 | 12640798 | 4 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 13.8 G, 2X/DAY | 0 | 13.8 | G | BID | |||||||
| 126407982 | 12640798 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | IN MORNING. | 0 | 300 | MG | QD | |||||||
| 126407982 | 12640798 | 6 | C | DALTEPARIN | DALTEPARIN | 1 | Subcutaneous | 18000 IU, 1X/DAY | 0 | 18000 | IU | QD | |||||||
| 126407982 | 12640798 | 7 | C | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | ONE DOSE RECEIVED ON 03.06.2016 AND ONE RECEIVED ON 10.06.2016. DRUG WITHHELD | 0 | 2200 | MG | ||||||||
| 126407982 | 12640798 | 8 | C | LENOGRASTIM | LENOGRASTIM | 1 | Subcutaneous | 263 UG, 1X/DAY | 8942 | UG | 0 | 263 | UG | QD | |||||
| 126407982 | 12640798 | 9 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | FOUR TIMES A DAY | 0 | 2 | DF | ||||||||
| 126407982 | 12640798 | 10 | C | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 830 MG, UNK | 0 | 830 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126407982 | 12640798 | 1 | Chemotherapy |
| 126407982 | 12640798 | 2 | Cellulitis |
| 126407982 | 12640798 | 3 | Prophylaxis |
| 126407982 | 12640798 | 7 | Chemotherapy |
| 126407982 | 12640798 | 10 | Chemotherapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126407982 | 12640798 | HO |
| 126407982 | 12640798 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126407982 | 12640798 | Cellulitis | |
| 126407982 | 12640798 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126407982 | 12640798 | 1 | 20160617 | 0 | ||
| 126407982 | 12640798 | 2 | 20160610 | 20160613 | 0 | |
| 126407982 | 12640798 | 7 | 20160603 | 0 | ||
| 126407982 | 12640798 | 8 | 20160612 | 20160614 | 0 | |
| 126407982 | 12640798 | 10 | 20160603 | 0 |